Oct 162017
 

By operator Feed Up

Talent4Boards - Great Talent builds Great Boards

– UK, London – Silence Therapeutics plc, (AIM:SLN), a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, today announced the appointment of Dr.=> Read more

Silence Therapeutics appoints Dr Annalisa Jenkins as Non-Executive Chair of the Board of Directors

From:: Silence Therapeutics appoints Dr Annalisa Jenkins as Non-Executive Chair of the Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: